Ally Bridge Group (Ny) LLC Macrogenics Inc Transaction History

Ally Bridge Group (Ny) LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $243,599 - $506,999	-30,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $5.33 Million - $7.33 Million	-335,000 Reduced 91.78%	30,000 $482,000
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $4.98 Million - $7.24 Million	252,161 Added 223.47%	365,000 $7.64 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $2.31 Million - $4.02 Million	112,839 New	112,839 $3.03 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.